Development and internal validation of a nomogram based on MRI and clinical features for predicting high ablation difficulty in ultrasound-guided HIFU for adenomyosis

In: Frontiers in Medicine · 2026 · vol. 13 · doi:10.3389/fmed.2026.1954919 · W7236114498
OA: gold CC0

Abstract

Objective To develop and internally validate a nomogram based on preprocedural magnetic resonance imaging (MRI) and clinical features to predict high ablation difficulty in patients with adenomyosis (AM) undergoing ultrasound-guided high-intensity focused ultrasound (US-guided HIFU). Methods This retrospective study included 486 patients with AM who underwent US-guided HIFU ablation. Patients were randomly divided in a 7:3 ratio into a training cohort ( n = 340) and an internal validation cohort ( n = 146). An ablation difficulty score ranging from 0 to 6 was established based on the energy efficiency factor (EEF), treatment intensity, and nonperfused volume ratio (NPVR). Patients were classified into a low-ablation-difficulty group (0–3 points) and a high-ablation-difficulty group (4–6 points). In the training cohort, candidate predictors were initially screened using univariable analysis and least absolute shrinkage and selection operator (LASSO) logistic regression. Multivariable logistic regression was subsequently performed to identify the final predictors and construct the nomogram. Model performance was evaluated in both cohorts using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Results Age, uterine volume, abdominal wall thickness, Kishi classification, T2-weighted imaging (T2WI) signal intensity, and the degree of contrast enhancement on T1-weighted imaging (T1WI) were identified as independent predictors of high ablation difficulty. The nomogram demonstrated good discrimination, with AUCs of 0.903 and 0.923 in the training and internal validation cohorts, respectively. Calibration curves showed good agreement between the predicted and observed probabilities. DCA indicated that the nomogram provided clinical net benefit across threshold probability ranges of approximately 5%–80% in the training cohort and 5%–75% in the internal validation cohort. Conclusion The nomogram based on preprocedural MRI and clinical features demonstrated good predictive performance for US-guided HIFU ablation difficulty in patients with AM and may support patient selection, preprocedural risk assessment, and individualized treatment planning.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
License: CC0 · commercial use OK